reference/32101563

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32101563

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	4349
issn	0006-4971 1528-0020
issueIdentifier	12
pageRange	4343-4349
publicationName	Blood
startingPage	4343
bibliographicCitation	Estey EH, Thall PF, Giles FJ, Wang XM, Cortes JE, Beran M, Pierce SA, Thomas DA, Kantarjian HM. Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinoside. Blood. 2002 Jun 15;99(12):4343–9. doi: 10.1182/blood.v99.12.4343. PMID: 12036860.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6d00d3aba027043e0cfebb59b17c883 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a772cdbe55a769a2f9df295a030f4bcf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ca7b0b93036ff9fda853d335b854f45 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2351ea09f1ffb258f50ce5fb3655f5b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_523976467e7f9f9652d772f62c818c37 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00c304015dcf3a55b0771b2f75801dd7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ee2ee9993fd3c12132278105f246372 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2e73ca33ee15ba233980af7634aabb0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d900df0b3edcd6207191a516aadc4a7
date	2002-06-15^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/12036860 https://doi.org/10.1182/blood.v99.12.4343
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1243 https://portal.issn.org/resource/ISSN/0006-4971 https://portal.issn.org/resource/ISSN/1528-0020
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinoside
discusses	http://id.nlm.nih.gov/mesh/M0448397 http://id.nlm.nih.gov/mesh/M0023493 http://id.nlm.nih.gov/mesh/M0398183 http://id.nlm.nih.gov/mesh/M0000946 http://id.nlm.nih.gov/mesh/M0026381 http://id.nlm.nih.gov/mesh/M0001373 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0005564
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009190Q000188 http://id.nlm.nih.gov/mesh/D017370Q000008 http://id.nlm.nih.gov/mesh/D000911Q000008 http://id.nlm.nih.gov/mesh/D000900Q000008 http://id.nlm.nih.gov/mesh/D007951Q000188 http://id.nlm.nih.gov/mesh/D000617 http://id.nlm.nih.gov/mesh/D000922Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D015255Q000493 http://id.nlm.nih.gov/mesh/D003561Q000008 http://id.nlm.nih.gov/mesh/D009190Q000401 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D007951Q000401 http://id.nlm.nih.gov/mesh/D015255Q000008 http://id.nlm.nih.gov/mesh/D007263 http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D012074Q000379 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D003561Q000493 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000208 http://id.nlm.nih.gov/mesh/D000754Q000188 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000079982 http://id.nlm.nih.gov/mesh/D013810 http://id.nlm.nih.gov/mesh/D001499
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8560 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42890 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_84e3de511fb7681468cc1f27cf429134 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9942071 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b3050902014fc7ce927183681cc3a991 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129367670 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129674956

Showing number of triples: 1 to 75 of 75.